Research Article
Toxicity of a Novel Herbomineral Preparation Las01 on Human Cancer Cell Lines and Its Safety Profile in Humans and Animals
Table 3
Determination of cytotoxicity by MTT assay.
|
| | MCF-7 | | | HeLa | | Laso1 conc. mg/L | Absorbance | % inhibition | % viability | Absorbance | % Inhibition | % viability |
| 10 | 2.009 | 4% | 95% | 2.008 | 5% | 92% | 25 | 2.001 | 10% | 90% | 2.002 | 12% | 89% | 50 | 1.991 | 15% | 84% | 1.990 | 16% | 80% | 100 | 1.850 | 35% | 64% | 1.850 | 38% | 65% | 150 | 1.720 | 41% | 59% | 1.719 | 45% | 55% | 200 | 1.562 | 46% | 45% | 1.561 | 47% | 42% | 250 | 1.320 | 51% | 48% | 1.321 | 57% | 38% | 300 | 1.250 | 66% | 39% | 1.252 | 68% | 32% | 350 | 1.110 | 70% | 32% | 1.109 | 70% | 29% | 400 | 1.001 | 72% | 30% | 1.002 | 74% | 25% | 450 | 1.000 | 75% | 24% | 1.001 | 76% | 20% | 500 | .950 | 77%. | 20% | .951 | 78% | 18% |
|
|